or
forgot password
  • cancer clinical trials in bronx, NY

  • FR901228 in Treating Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma (Cancer) of the Head and Neck
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Brain Tumor, Central Nervous System Tumor
    Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
    Our Lady of Mercy Medical Center Comprehensive Cancer Center
    Bronx, New York 10466
    Kidney Cancer
    Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma
    Our Lady of Mercy Medical Center
    Bronx, New York 10466
    Non-Hodgkin's Lymphoma
    Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Sarcoma
    Levocarnitine in Treating Fatigue in Cancer Patients
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Brain and Central Nervous System Tumors
    Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Adenocarcinoma of the Rectum, Mucinous Adenocarcinoma of the Colon, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    Local Institution
    Bronx, New York
    Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-positive
    Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
    Local Institution
    Bronx, New York
    Transitional Cell Carcinoma, Bladder Neoplasms, Kidney Neoplasms, Ureter Neoplasms, Bladder Cancer, Neoplasm, Bladder
    Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
    Local Institution
    Bronx, New York
    Chronic Myelogenous Leukemia
    Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
    Local Institution
    Bronx, New York
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Bronx, New York 10461
    Colorectal Neoplasms
    ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
    Jacobi Medical Center
    Bronx, New York 10461
    Pancreatic Cancer, Adenocarcinoma
    Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Albert Einstein Cancer Center at Albert Einstein College of Medicine

    Trial Locations
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Our Lady of Mercy Medical Center Comprehensive Cancer Center
    Head and Neck Cancer
    Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
    Pfizer Investigational Site
    Bronx, New York 10461
    Adenocarcinoma, Neoplasms
    Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
    Sickle Cell Center, Montefiore Hospital
    Bronx, New York 10467
    Sickle Cell Disease, Iron Overload, Hemolytic Anemia
    Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Bronx, New York 10461
    Carcinoma, Renal Cell
    Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
    Pfizer Investigational Site
    Bronx, New York 10461
    Lymphoma
    Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Stage III Melanoma, Stage IV Melanoma
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Breast Cancer
    AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Endometrial Cancer
    Palliative Care Study in Patients With Advanced Cancer
    Jacobi Medical Center
    Bronx, New York 10461
    Cancer
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Bronx, New York 10461
    Colorectal Neoplasms
    Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Bronx, New York 10461
    Carcinoma, Non-Small-Cell Lung
    MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
    Pfizer Investigational Site
    Bronx, New York 10461
    Melanoma, Colonic Neoplasms, Breast Neoplasms
    Abatacept With Methotrexate- Phase IIB
    Local Institution
    Bronx, New York
    Rheumatoid Arthritis
    MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Bronx, New York 10461
    Carcinoma, Non-Small-Cell Lung
    Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
    Pfizer Investigational Site
    Bronx, New York 10461
    Breast Neoplasms
    Natural History of Oro-pharyngeal Cancer Precursors
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Precancerous Conditions, Leukoplakia, Erythroplasia, Oral Papillomas
    Safety And Efficacy In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin’s Lymphoma
    New York Medical Center, MBCCOP
    Bronx, New York 10466
    Non-Hodgkins Lymphoma
    Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma
    New York Medical Center, MBCCOP
    Bronx, New York 10466
    Non-Hodgkins Lymphoma
    Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
    Pfizer Investigational Site
    Bronx, New York 10461
    Neoplasms
    Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
    Montefiore Medical Center

    Trial Locations
    Montefiore Medical Center
    Jacobi Medical Center
    Albert Einstein Cancer Center
    Non-Small Cell Lung Cancer
    Assessment of Early Genetic Changes in Smokers
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Cancer of Head and Neck, Smoking
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Bronx, New York 10461
    Osteoporosis
    A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Squamous Cell Carcinoma of the Head and Neck
    Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
    Our Lady of Mercy Medical Center Comprehensive Cancer Center
    Bronx, New York 10466
    Lymphoma
    A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Uterine Cancer
    A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Uterine Cancer
    Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
    Montefiore Medical Center
    Bronx, New York 10467-2490
    Ovarian Neoplasms, Uterine Neoplasms
    Patient Centered Randomized Controlled Trial
    Albert Einstein College of Medicine

    Trial Locations
    Albert Einstein College of Medicine
    Montefiore Medical Center
    Early-Stage Breast Cancer
    Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
    Pfizer Investigational Site
    Bronx, New York 10461
    Carcinoma, Non-Small-Cell Lung
    Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
    Albert Einstein Cancer Center at Albert Einstein College of Medicine
    Bronx, New York 10461
    Breast Cancer